Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 61 articles:
HTML format
Text format



Single Articles


    March 2019
  1. BOLLYKY TJ, Templin T, Cohen M, Schoder D, et al
    The relationships between democratic experience, adult health, and cause-specific mortality in 170 countries between 1980 and 2016: an observational analysis.
    Lancet. 2019 Mar 13. pii: S0140-6736(19)30235.
    PubMed     Text format     Abstract available


  2. PAGE KR, Doocy S, Reyna Ganteaume F, Castro JS, et al
    Venezuela's public health crisis: a regional emergency.
    Lancet. 2019 Mar 11. pii: S0140-6736(19)30344.
    PubMed     Text format     Abstract available


  3. THE LANCET
    Ending HIV in the USA.
    Lancet. 2019;393:960.
    PubMed     Text format    


    February 2019
  4. THE LANCET
    Russia's burgeoning HIV epidemic.
    Lancet. 2019;393:612.
    PubMed     Text format    


  5. JAFFE S
    USA sets goal to end the HIV epidemic in a decade.
    Lancet. 2019;393:625-626.
    PubMed     Text format    


  6. CARRAT F, Fontaine H, Dorival C, Simony M, et al
    Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
    Lancet. 2019 Feb 11. pii: S0140-6736(18)32111.
    PubMed     Text format     Abstract available


  7. COE IR, Wiley R, Bekker LG
    Organisational best practices towards gender equality in science and medicine.
    Lancet. 2019;393:587-593.
    PubMed     Text format     Abstract available


  8. GOSTIN L, Phelan A, Coutinho AG, Eccleston-Turner M, et al
    Ebola in the Democratic Republic of the Congo: time to sound a global alert?
    Lancet. 2019 Feb 1. pii: S0140-6736(19)30243.
    PubMed     Text format    


    January 2019
  9. MICHAUD J, Moss K, Licina D, Waldman R, et al
    Militaries and global health: peace, conflict, and disaster response.
    Lancet. 2019;393:276-286.
    PubMed     Text format     Abstract available


  10. KROIDL A, Eberle J
    A two-drug regimen for antiretroviral therapy.
    Lancet. 2019;393:106-108.
    PubMed     Text format    


    December 2018
  11. KIRBY T
    The UK reaches UNAIDS 90-90-90 targets.
    Lancet. 2018;392:2427.
    PubMed     Text format    


  12. THE LANCET
    CRISPR-Cas9: a world first?
    Lancet. 2018;392:2413.
    PubMed     Text format    


  13. ZHANG L, Zhong P, Zhai X, Shao Y, et al
    Open letter from Chinese HIV professionals on human genome editing.
    Lancet. 2018 Dec 3. pii: S0140-6736(18)33082.
    PubMed     Text format    


  14. PETRONI S, Ngo TD
    Stemming HIV in adolescents: gender and modes of transmission.
    Lancet. 2018;392:2335-2336.
    PubMed     Text format    


  15. ADEYEYE AO, Stirratt MJ, Burns DN
    Engaging men in HIV treatment and prevention.
    Lancet. 2018;392:2334-2335.
    PubMed     Text format    


    November 2018
  16. KIRBY T
    Susan Buchbinder: driving HIV prevention efforts worldwide.
    Lancet. 2018;392:2161.
    PubMed     Text format    



  17. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    Lancet. 2018;392:1684-1735.
    PubMed     Text format     Abstract available


  18. CAHN P, Madero JS, Arribas JR, Antinori A, et al
    Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-infe
    Lancet. 2018 Nov 9. pii: S0140-6736(18)32462.
    PubMed     Text format     Abstract available


  19. HAAKENSTAD A, Moses M, Dieleman JL
    Comparing estimates of spending on health and HIV/AIDS - Authors' reply.
    Lancet. 2018;392:1622.
    PubMed     Text format    


  20. IZAZOLA-LICEA JA, Yakusik A, Mattur D
    Comparing estimates of spending on health and HIV/AIDS.
    Lancet. 2018;392:1621-1622.
    PubMed     Text format    


    October 2018
  21. FOREMAN KJ, Marquez N, Dolgert A, Fukutaki K, et al
    Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories.
    Lancet. 2018 Oct 16. pii: S0140-6736(18)31694.
    PubMed     Text format     Abstract available


    September 2018
  22. AHMAD N, Ahuja SD, Akkerman OW, Alffenaar JC, et al
    Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
    Lancet. 2018;392:821-834.
    PubMed     Text format     Abstract available


  23. MILLER WC, Hoffman IF, Hanscom BS, Ha TV, et al
    A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study.
    Lancet. 2018;392:747-759.
    PubMed     Text format     Abstract available


  24. JARLAIS DCD, Duong HT
    Ending HIV epidemics among people who inject drugs in LMICs.
    Lancet. 2018;392:714-716.
    PubMed     Text format    


    August 2018
  25. BELETSKY L, Baker P, Arredondo J, Emuka A, et al
    The global health and equity imperative for safe consumption facilities.
    Lancet. 2018;392:553-554.
    PubMed     Text format    


  26. MCCALL B
    Scientific evidence against HIV criminalisation.
    Lancet. 2018;392:543-544.
    PubMed     Text format    


  27. BURZA S, Croft SL, Boelaert M
    Leishmaniasis.
    Lancet. 2018 Aug 17. pii: S0140-6736(18)31204.
    PubMed     Text format     Abstract available


    July 2018
  28. GHOSN J, Taiwo B, Seedat S, Autran B, et al
    HIV.
    Lancet. 2018 Jul 23. pii: S0140-6736(18)31311.
    PubMed     Text format     Abstract available


  29. BAROUCH DH, Tomaka FL, Wegmann F, Stieh DJ, et al
    Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
    Lancet. 2018;392:232-243.
    PubMed     Text format     Abstract available


  30. PAVLAKIS GN, Felber BK
    A new step towards an HIV/AIDS vaccine.
    Lancet. 2018;392:192-194.
    PubMed     Text format    


  31. WEBSTER P
    PEPFAR at 15 years.
    Lancet. 2018;392:200.
    PubMed     Text format    


  32. NAKKAZI E
    Changes to dolutegravir policy in several African countries.
    Lancet. 2018;392:199.
    PubMed     Text format    


  33. SHANNON K, Crago AL, Baral SD, Bekker LG, et al
    The global response and unmet actions for HIV and sex workers.
    Lancet. 2018 Jul 20. pii: S0140-6736(18)31439.
    PubMed     Text format     Abstract available


  34. DAS P, Horton R
    Beyond the silos: integrating HIV and global health.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31466.
    PubMed     Text format    


  35. MAKOFANE K, Spire B, Mtetwa P
    Tackling global health inequities in the HIV response.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31441.
    PubMed     Text format    


  36. SANDS P
    HIV: from exceptionalism to endgame.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31434.
    PubMed     Text format    


  37. GUPTA-WRIGHT A, Corbett EL, van Oosterhout JJ, Wilson D, et al
    Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31267.
    PubMed     Text format     Abstract available


  38. NATHAVITHARANA RR, Pai M
    New strategies for inpatients with HIV and tuberculosis.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31442.
    PubMed     Text format    


  39. BEKKER LG, Alleyne G, Baral S, Cepeda J, et al
    Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31070.
    PubMed     Text format    


    June 2018
  40. THE LANCET
    Dolutegravir for HIV: a lesson in pregnancy safety research.
    Lancet. 2018;391:2296.
    PubMed     Text format    


  41. MCBRIDE B, Mitra S, Kondo V, Elmi H, et al
    Unpaid labour, #MeToo, and young women in global health.
    Lancet. 2018;391:2192-2193.
    PubMed     Text format    


  42. THE LANCET
    Active case finding for communicable diseases in prisons.
    Lancet. 2018;391:2186.
    PubMed     Text format    


    May 2018
  43. NISHTAR S, Niinisto S, Sirisena M, Vazquez T, et al
    Time to deliver: report of the WHO Independent High-Level Commission on NCDs.
    Lancet. 2018 May 31. pii: S0140-6736(18)31258.
    PubMed     Text format    


  44. ZAROCOSTAS J
    HIV/AIDS community divided over allegations about UNAIDS.
    Lancet. 2018;391:1984.
    PubMed     Text format    


    April 2018
  45. COSTELLO A
    The Global Fund links with Lombard Odier bank.
    Lancet. 2018;391:1674-1675.
    PubMed     Text format    


  46. ZAROCOSTAS J
    Claims of sexual harassment and assault threaten UN agency.
    Lancet. 2018;391:1561-1565.
    PubMed     Text format    



  47. Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995-2015.
    Lancet. 2018 Apr 17. pii: S0140-6736(18)30698.
    PubMed     Text format     Abstract available


    March 2018
  48. OLAKUNDE BO, Adeyinka DA, Wakdok SS, Oladele TT, et al
    Quantification of the effect of terrorism on the HIV response in Nigeria.
    Lancet. 2018;391:1257-1258.
    PubMed     Text format    


  49. GOOSBY E, Jamison D, Swaminathan S, Reid M, et al
    The Lancet Commission on tuberculosis: building a tuberculosis-free world.
    Lancet. 2018;391:1132-1133.
    PubMed     Text format    


  50. BROWNE JL, Smit MR, Angira F, van der Graaf R, et al
    Good intentions do not replace ethical conduct in research.
    Lancet. 2018;391:1020-1021.
    PubMed     Text format    


    February 2018
  51. THAPA S
    Women helping women prevent HIV in resource-limited settings.
    Lancet. 2018;391:738-739.
    PubMed     Text format    


    January 2018
  52. KARAMOUZIAN M, Kerr T
    A public health approach to opioid addiction in North America.
    Lancet. 2018;391:201-202.
    PubMed     Text format    


  53. LLIBRE JM, Hung CC, Brinson C, Castelli F, et al
    Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies.
    Lancet. 2018 Jan 5. pii: S0140-6736(17)33095.
    PubMed     Text format     Abstract available


  54. BICCARD BM, Madiba TE, Kluyts HL, Munlemvo DM, et al
    Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study.
    Lancet. 2018 Jan 3. pii: S0140-6736(18)30001.
    PubMed     Text format     Abstract available


    December 2017
  55. BERNARDO EL, Fuente-Soro L, Lopez-Varela E, Naniche D, et al
    Anonymity in HIV testing: implications for public health.
    Lancet. 2017;390:2546.
    PubMed     Text format    


    October 2017
  56. LAMONTAGNE F, Fowler RA, Adhikari NK, Murthy S, et al
    Evidence-based guidelines for supportive care of patients with Ebola virus disease.
    Lancet. 2017 Oct 17. pii: S0140-6736(17)31795.
    PubMed     Text format     Abstract available


  57. IYER JK, Mendelson M
    Can the Antimicrobial Resistance Benchmark blaze a new trail?
    Lancet. 2017 Oct 13. pii: S0140-6736(17)32670.
    PubMed     Text format    


    September 2017
  58. POKROVSKY V
    Tuberculosis and HIV/AIDS: the alien and the predator.
    Lancet. 2017;390:1618-1619.
    PubMed     Text format    


  59. KAZATCHKINE MD
    Health in the Soviet Union and in the post-Soviet space: from utopia to collapse and arduous recovery.
    Lancet. 2017;390:1611-1612.
    PubMed     Text format    



  60. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet. 2017;390:1151-1210.
    PubMed     Text format     Abstract available



  61. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet. 2017;390:1084-1150.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: